| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/28/2009 | CN101355958A Interferon-alpha and c-phycocyanin for the treatment of autoimmune diseases, allergic diseases and cancer |
| 01/28/2009 | CN101355954A Therapeutic agent for metabolic syndrome and food containingthe therapeutic agent |
| 01/28/2009 | CN101355952A Compositions useful for reducing nephrotoxicity and methods of use thereof |
| 01/28/2009 | CN101355951A Novel opioid antagonists |
| 01/28/2009 | CN101355950A Rifamycin analogs and uses thereof |
| 01/28/2009 | CN101355949A Combination of triazine derivatives and insulin secretion stimulators |
| 01/28/2009 | CN101355948A Combination of Roscovitine and a HDCA inhibitor to treat prolifeative diseases |
| 01/28/2009 | CN101355947A Thiazolopyrimidines for use in therapy |
| 01/28/2009 | CN101355946A Compounds for modulating TRPV3 function |
| 01/28/2009 | CN101355945A Combination of ZD6474 and pemetrexed |
| 01/28/2009 | CN101355944A Diaryl ureas for treating pulmonary hypertension |
| 01/28/2009 | CN101355943A Therapeutic agent for nausea and/or vomiting |
| 01/28/2009 | CN101355942A Solid dispersions of opioid antagonists |
| 01/28/2009 | CN101355941A Diaryl ureas for treating pulmonary hypertension |
| 01/28/2009 | CN101355940A In vivo or in vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 01/28/2009 | CN101355939A Composition and synthesis of new reagents for inhibition of HIV replication |
| 01/28/2009 | CN101355938A Pharmaceutical use of substituted amides |
| 01/28/2009 | CN101355937A Use of tiotropium salts in the treatment of moderate persistent asthma |
| 01/28/2009 | CN101355936A Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic |
| 01/28/2009 | CN101355935A Combination of triazine derivatives and HMG-COA reductase inhibitors for the treatment of diabetes |
| 01/28/2009 | CN101355934A Transcription set modifier and application of chemotherapeutics or actinotheraphy against cancer |
| 01/28/2009 | CN101355933A Combination of triazine derivatives and insulin sensitisers |
| 01/28/2009 | CN101355932A Combination of triazine derivatives and PPAR alfa agonists |
| 01/28/2009 | CN101355931A Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect |
| 01/28/2009 | CN101355930A Milnacipran for the long- term treatment of fibromyalgia syndrome |
| 01/28/2009 | CN101355929A Means and methods for the treatment and prevention of allergic diseases |
| 01/28/2009 | CN101355928A Compositions and methods for cancer immunotherapy |
| 01/28/2009 | CN101355924A Use of ceramides for depigmenting the skin |
| 01/28/2009 | CN101355876A Methods, compositions, and kits for the treatment of medical conditions |
| 01/28/2009 | CN101354397A Strategy for retroviral immunotherapy |
| 01/28/2009 | CN101353664A siRNA molecule expression vector for specific inhibition of IL-6 receptor protein expression, and construction method and use thereof |
| 01/28/2009 | CN101353656A siRNA inhibiting expression of epidermal growth factor receptor genes and use thereof |
| 01/28/2009 | CN101353655A siRNA inhibiting expression of vascular endothelial growth factor receptor genes and use thereof |
| 01/28/2009 | CN101353430A Method for preparing amylose water solution |
| 01/28/2009 | CN101353378A Zone 2 protein of programmed cell death protein 2 analogue and uses thereof |
| 01/28/2009 | CN101353377A Zone 1 protein of programmed cell death protein 2 analogue and uses thereof |
| 01/28/2009 | CN101353368A Pregna medicament for treating tumor |
| 01/28/2009 | CN101353366A Steroidal estrogen medicament for treating tumor |
| 01/28/2009 | CN101353362A Extraction method of cyaniding 3-0-glucoside |
| 01/28/2009 | CN101353361A Preparation of adriablastina prodrug and use thereof |
| 01/28/2009 | CN101353357A Organo-tin compound, preparation and use thereof |
| 01/28/2009 | CN101353351A Novel 2,3,3a,4-tetrahydro thiochromeno [4,3-c] pyrazole antiinflammatory antimycotic compound |
| 01/28/2009 | CN101353348A 7-[4-(aminomethyl)-4-fluoro-3-(alkoxyimine) pyrrolidine-1-yl] substituted quinoline carboxylic acid derivative and preparation thereof |
| 01/28/2009 | CN101353346A Puerarin amino acid ester derivative and medicine use thereof |
| 01/28/2009 | CN101353344A Pyrazolyl-substituted heterocycles and their use as phytosanitary products |
| 01/28/2009 | CN101353339A Synthesis of quercetin platinum |
| 01/28/2009 | CN101353333A 10- deacetylate-9(R)-hydrogenization-1-deoxypaclitaxel analogue and preparation thereof |
| 01/28/2009 | CN101353326A 2-hydroxy phenyl-1H-benzimidazole-4-acidamide type derivates |
| 01/28/2009 | CN101353320A Matrix metalloprotease inhibitors, medicinal composition containing the same, preparation and use thereof |
| 01/28/2009 | CN101352564A Novel medical use of pills for resuscitation and reconstruction |
| 01/28/2009 | CN101352555A Chinese medicine for treating irregular menstruation and preparation method thereof |
| 01/28/2009 | CN101352543A Walnut tuckahoe oral liquid and method for producing the same |
| 01/28/2009 | CN101352541A Medicament and preparation method thereof for treating common diseases in home |
| 01/28/2009 | CN101352537A Chinese medicine preparation for treating painful swelling of throat |
| 01/28/2009 | CN101352522A Chinese medicine ointment formulation for treating burn and preparation method thereof |
| 01/28/2009 | CN101352521A Onychomycosis medicine and preparation method thereof |
| 01/28/2009 | CN101352516A Safety high-efficient pilatory and preparation method |
| 01/28/2009 | CN101352507A Capsules for treating angina pectoris |
| 01/28/2009 | CN101352504A Bedsore plaster and method for producing the same |
| 01/28/2009 | CN101352499A Nidaodier tablet medicine |
| 01/28/2009 | CN101352498A Formulation for reducing medicine toxicity damage and improving immunity and regulating blood sugar and preparation method thereof |
| 01/28/2009 | CN101352497A Chinese medicinal composition for removing chloasma, and preparation method and uses thereof |
| 01/28/2009 | CN101352492A Medicament composition for treating cardio-cerebrovascular disease and regulating blood fat |
| 01/28/2009 | CN101352483A Medicine for treating diabetes |
| 01/28/2009 | CN101352479A Medicament for treating gastritis and preparation method thereof |
| 01/28/2009 | CN101352473A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352472A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352471A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352470A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352469A Pharmaceutical combination for preventing birth-defect and improving memory |
| 01/28/2009 | CN101352466A Chinese medicinal composition and uses thereof |
| 01/28/2009 | CN101352454A External-use gel foamable composition for gynecology inflammation and obesity |
| 01/28/2009 | CN101352453A Pharmaceutical composition for preventing intestinal adhesion |
| 01/28/2009 | CN101352452A Pharmaceutical composition capable of preventing and treating oviduct adhesions |
| 01/28/2009 | CN101352451A Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
| 01/28/2009 | CN101352450A Prescription of compound external-use ulcer powder |
| 01/28/2009 | CN101352449A Vitamin orally disintegrating tablet and preparation method thereof |
| 01/28/2009 | CN101352448A Use of Liriope muscari Bailey C in pharmacy |
| 01/28/2009 | CN101352447A Use of oligosaccharides molecule in preparing contraceptive medicament |
| 01/28/2009 | CN101352446A Compound and use for the treatment of benign prostatic hyperplasia and relative diseases |
| 01/28/2009 | CN101352445A Novel use of chuanbeinone compounds |
| 01/28/2009 | CN101352444A New use of tripterine in pharmacy |
| 01/28/2009 | CN101352443A Male-sterilant for mammalian |
| 01/28/2009 | CN101352442A Sustained release tablets containing cefaclor active component and preparation method thereof |
| 01/28/2009 | CN101352441A Brimonidine tartrate in situ forming eye gel |
| 01/28/2009 | CN101352440A Guaifenesin, pseudoephedrine hydrochloride and dextromethorphan hydrobromide sustained-release preparation and preparation method thereof |
| 01/28/2009 | CN101352439A Composition injection containing tetrandrine and preparation method thereof |
| 01/28/2009 | CN101352438A Uses of deferiprone and formulation thereof in preparing medicament for preventing and treating cardiotoxicity induced by anthracyclines |
| 01/28/2009 | CN101352437A Use of amaryllidaceae alkaloid as tumour anti-apoptosis factor Mc1-1 inhibitor |
| 01/28/2009 | CN101352436A Novel medicament composition for resisting thrombosis |
| 01/28/2009 | CN101352435A Use of lipoamide for preventing and treating age related macular degeneration |
| 01/28/2009 | CN101352434A Use of triptolide in preparing medicament for treating c-KIT tyrosine kinase related tumor |
| 01/28/2009 | CN101352433A Formulation capable of effectively balancing blood pressure, blood fat and promoting cardio-cerebral arterial vascular softening, and preparation method thereof |
| 01/28/2009 | CN101352432A Technique of preparing nano vitamin E emulsion |
| 01/28/2009 | CN101352431A Medicament for resisting allergic diseases |
| 01/28/2009 | CN101352430A Compound formulation containing carthamus tinctorius yellow colour B and uses thereof |
| 01/28/2009 | CN101352429A Use of tiopronin in preparing medicament for treating liver function damage induced by cerebral ischemia, diabetes and obesity |
| 01/28/2009 | CN101352428A Solid preparation containing ibuprofen and tranexamic acid |
| 01/28/2009 | CN101352427A Use of shikimic acid in preparing medicament for treating ulcerative colitis |
| 01/28/2009 | CN101352426A Osmotic pump controlled release preparation composition and preparation thereof |